SMTL ID : 6umh.1 (1 other biounit)

Crystal structure of erenumab Fab-a

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

hetero-1-1-mer

Ligands

3 x PDO: 1,3-PROPANDIOL(Non-covalent)

PDO.1: 5 residues within 4Å: Chain A: D.99, Y.114, G.116 Chain B: S.35, T.91 2 PLIP interactions: 1 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:S.35, A:D.99 PDO.2: 8 residues within 4Å: Chain A: K.160, D.161, Q.188, S.194 Chain B: T.135, E.164, Y.181, S.183 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:S.194 Water bridges: A:Q.188, B:E.164 Hydrophobic interactions: B:T.135 PDO.6: 6 residues within 4Å: Chain A: T.200 Chain B: T.118, V.119, T.120, L.139, S.141 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:T.118, B:T.120, B:S.141, A:H.181

6 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.3: 4 residues within 4Å: Chain A: K.134, S.137, D.161 Chain B: K.133 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:S.137, A:S.137, A:S.137 Salt bridges: A:K.134, B:K.133 PO4.4: 3 residues within 4Å: Chain A: S.107, G.108, Y.109 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.107, A:G.108 PO4.7: 6 residues within 4Å: Chain B: E.84, T.108, V.109, Y.144, K.170, Y.176 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:Y.144, B:Y.176 Water bridges: B:K.106, B:G.111, B:Y.176 Salt bridges: B:K.170 PO4.8: 6 residues within 4Å: Chain A: K.43, G.44 Chain B: D.86, Y.88, G.103, G.104 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:D.86, B:Y.88, B:G.103 PO4.9: 4 residues within 4Å: Chain B: N.116, H.201, E.202, S.204 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:N.116, B:S.204, B:S.204 Water bridges: B:N.116, B:N.116, B:H.201 PO4.10: 6 residues within 4Å: Chain B: G.30, N.31, N.32, Y.33, N.52, K.67 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:N.32, B:N.52, B:N.52 Salt bridges: B:K.67

1 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)

MPD.5: 9 residues within 4Å: Chain A: K.146, S.147, S.149, T.152, A.154 Chain B: T.118, V.119, T.120, K.208 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:T.152, A:A.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garces, F. et al., Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab). Cell Rep (2020)

Release Date

2020-02-12

Peptides

erenumab Fab heavy chain, IgG1: A
erenumab Fab light chain, IgG1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

erenumab Fab heavy chain, IgG1

erenumab Fab light chain, IgG1

Related Entries With Identical Sequence